$46.0 Million
Eiger BioPharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$69.0 Million
Zafgen, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$46.0 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$57.5 Million
Synlogic, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.0 Million
Adverum Biotechnologies, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$46.0 Million
Fate Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$38.0 Million
Novan, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$37.4 Million
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$250.0 Million
Prothena Corporation plc
At the Market Offering
Left Bookrunner
$650.0 Million
BridgeBio Pharma, Inc.
Convertible Offering
Passive Bookrunner
Subscribe to Financing

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.